Chikungunya infected children are being reported these days, said Dr. Deepal Perera, a specialist at the Lady Ridgeway ...

Valneva’s growth potential lies in Ixchiq, but risks remain. Find out why VALN stock is still a Buy with a good long-term ...

Cases of Chikungunya among children are being reported in recent days, Lady Ridgeway Hospital’s Consultant Paediatrician Dr. Deepal Perera said. Dr.

Two deaths and 16 fresh suspected cases of Guillain-Barré Syndrome (GBS) were reported in Pune and other districts, the ...

Valneva has announced positive outcomes from its Phase III VLA1553-321 trial of the single-shot IXCHIQ chikungunya virus ...

A woman is suspected to have died of Guillain-Barré syndrome (GBS) in Maharashtra on Wednesday, while 16 new cases of the ...

This action follows an executive order signed by President Trump on his first day in office to withdraw the United States ...

A 56-year-old woman in Pune, India, is suspected to have died from Guillain-Barré Syndrome (GBS). 127 suspected GBS cases ...

Valneva’s vaccine was highly immunogenic in both dose groups. A full dose of the vaccine exhibited a more robust immune response compared to a half dose by providing protective antibody titers already ...

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today reported further positive Phase 3 data in adolescents for its single-shot chikungunya virus (CHIKV) vaccine, IXCHIQ®, ...

Valneva has shared positive results from a late-stage study of its single-dose chikungunya vaccine in adolescents aged 12 to ...